Okumura K, Osanai T, Kosugi T, Hanada H, Ishizaka H, Fukushi T, Kamada T, Miura T, Hatayama T, Nakano T, Fujino Y, Homma Y
Second Department of Internal Medicine, Hirosaki University School of Medicine, Japan.
J Am Coll Cardiol. 2000 Nov 15;36(6):1847-52. doi: 10.1016/s0735-1097(00)00966-9.
We measured phospholipase C (PLC) activity in the cultured skin fibroblasts obtained from patients with and without coronary spasm and examined its correlation with coronary artery vasomotility.
Coronary artery vasomotility is enhanced in coronary spastic angina (CSA), but no information is available for the intracellular signaling. In spontaneously hypertensive rats, PLC activity in the skin fibroblasts has been shown to be enhanced.
Skin fibroblasts obtained from 24 patients with CSA-14 with organic coronary artery disease (CAD) and 12 control subjects--were cultured by the explant method. Activity of PLC was determined by incubating the membrane fraction with 3H-phosphatidyl inositol bisphosphate and by quantifying 3H-inositol trisphosphate. In patients with CSA and control subjects, the relations between PLC activity and coronary artery basal tone and constrictor response to intracoronary acetylcholine (ACh) were examined.
Activity of PLC (pmol/protein [mg] per min) was 1.74+/-0.19 in patients with CSA; 0.90+/-0.12 in patients with CAD; and 0.65+/-0.07 in control subjects (p<0.001, patients with CSA vs. patients with CAD and control subjects; p = NS, patients with CAD vs. control subjects). According to the Lineweaver-Burk plot, Michaelis constant (micromol/liter) of PLC was 28+/-4 in patients with CSA; 49+/-14 in patients with CAD; and 56+/-10 in control subjects (p<0.05, patients with CSA vs. control subjects), whereas the maximal velocity was not different between the three groups. There were significant positive correlations between PLC activity and both basal tone (p = 0.0108) and response to ACh (p = 0.0053). Western blot analysis using membrane fraction demonstrated that 89% of PLC isoenzymes detected was of the delta1 isoform.
Because the PLC activity measured was genetically defined and was positively correlated with coronary artery vasomotility, enhanced PLC activity may be involved in the pathogenesis of coronary spasm.
我们测定了有和没有冠状动脉痉挛的患者培养的皮肤成纤维细胞中的磷脂酶C(PLC)活性,并检查其与冠状动脉血管舒缩功能的相关性。
冠状动脉痉挛性心绞痛(CSA)患者的冠状动脉血管舒缩功能增强,但关于细胞内信号传导尚无相关信息。在自发性高血压大鼠中,已证明皮肤成纤维细胞中的PLC活性增强。
采用组织块培养法培养从24例CSA患者(14例合并器质性冠状动脉疾病[CAD])和12例对照者获取的皮肤成纤维细胞。通过将膜组分与3H-磷脂酰肌醇二磷酸孵育并定量3H-肌醇三磷酸来测定PLC活性。在CSA患者和对照者中,检查了PLC活性与冠状动脉基础张力以及对冠状动脉内乙酰胆碱(ACh)的收缩反应之间的关系。
CSA患者的PLC活性(每分钟每毫克蛋白质的pmol数)为1.74±0.19;CAD患者为0.90±0.12;对照者为0.65±0.07(CSA患者与CAD患者及对照者相比,p<0.001;CAD患者与对照者相比,p =无显著性差异)。根据Lineweaver-Burk图,CSA患者PLC的米氏常数(微摩尔/升)为28±4;CAD患者为49±14;对照者为56±10(CSA患者与对照者相比,p<0.05),而三组之间的最大速度无差异。PLC活性与基础张力(p = 0.0108)和对ACh的反应(p = 0.0053)均呈显著正相关。使用膜组分的蛋白质印迹分析表明,检测到的PLC同工酶89%为δ1亚型。
由于所测定的PLC活性是由基因决定的,并且与冠状动脉血管舒缩功能呈正相关,因此增强的PLC活性可能参与冠状动脉痉挛的发病机制。